Healthy Participants clinical trials

Explore recruiting healthy participants clinical trials.

Recruiting healthy participants studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Participants trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

Spain

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Examining the effects of intravenous oxytocin infusion on peripheral sensory afferents using microneurography technique in healthy volunteers: a triple-blind, randomized, placebo-controlled trial

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

An Experimental Medicine multicenter Trial to evaluate the safety and immunogenicity of experimental versus authorized SARS-CoV-2 vaccine candidates as a booster dose in healthy participants previously vaccinated with authorized mRNA SARS-CoV-2 vaccines.

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Effect of Modafinil on military observational performance and residual capacity of the Dutch Air Assault Brigade: a field trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

AN OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE THE RELATIVE BIOAVAILABILITY OF A NEW TABLET FORMULATION OF MINZASOLMIN AND THE POTENTIAL EFFECT OF FOOD ON THE PHARMACOKINETICS OF MINZASOLMIN IN HEALTHY PARTICIPANTS

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A study to learn if UCB3101 is safe and how it moves through the body of healthy participants

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Healthy Participants trials by city

Healthy Participants in Toronto Healthy Participants in Vancouver Healthy Participants in Montreal Healthy Participants in Calgary Healthy Participants in Edmonton Healthy Participants in Ottawa Healthy Participants in Winnipeg Healthy Participants in Quebec City Healthy Participants in Hamilton Healthy Participants in Kitchener Healthy Participants in London Healthy Participants in Halifax Healthy Participants in New York Healthy Participants in Los Angeles Healthy Participants in Chicago Healthy Participants in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease